Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Body Fat Distribution
|
119 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Secondary malignant neoplasm of lymph node
|
188 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Cardiovascular Diseases
|
711 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
cervical cancer
|
268 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Cervix carcinoma
|
283 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Hypertensive disease
|
1085 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||
Malignant tumor of cervix
|
245 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Neuroendocrine Tumors
|
20 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Liver Cirrhosis
|
189 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Squamous cell carcinoma of oropharynx
|
33 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Febrile Neutropenia
|
14 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Lymphoma, Non-Hodgkin
|
197 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Diabetes
|
710 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Diabetes Mellitus
|
824 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Non-Small Cell Lung Carcinoma
|
712 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Coronary Artery Disease
|
1577 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.020 | 1.000 | 2 | 2012 | 2012 | ||||
Ischemic stroke
|
704 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.020 | 1.000 | 2 | 2012 | 2014 | ||||
Liver carcinoma
|
942 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.020 | 1.000 | 2 | 2012 | 2015 | ||||
Neoplasm Metastasis
|
327 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.020 | 0.500 | 2 | 2012 | 2017 | ||||
Cholelithiasis
|
90 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Head and Neck Carcinoma
|
118 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Islet Cell Tumor
|
5 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Malignant Head and Neck Neoplasm
|
118 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Oropharynx (excludes nasopharynx)
|
5 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 |